Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03181594 · ClinicalTrials.gov registry record · NA
Evaluation of the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis
A NA study, sponsored by Arrinex.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03181594 is a NA study that has completed, run by Arrinex. The registered enrollment target is 100 participants.
The verdict
NCT03181594, a NA study, has completed, sponsored by Arrinex.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
A multi-center, prospective, non-randomized, interventional clinical trial to assess the safety and effectiveness of the ClariFix™ device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.
Interventions
- DEVICE ClariFix Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-03-02 |
| Est. Completion | 2020-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03181594
The ClinicalTrials.gov registry entry for NCT03181594 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arrinex, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ClariFix Device is the first listed.
NCT03181594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03181594 about?
NCT03181594 is a clinical study titled "Evaluation of the ClariFix™ Cryotherapy Device in Subjects With Chronic Rhinitis". A multi-center, prospective, non-randomized, interventional clinical trial to assess the safety and effectiveness of the ClariFix™ device when used to ablate unwanted tissue in the nose of subjects with chronic rhinitis.
What is the current status of trial NCT03181594?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-03-02. Estimated completion is 2020-04-06.
What interventions are being tested in trial NCT03181594?
The interventions under investigation include: ClariFix Device (DEVICE).
Who is sponsoring clinical trial NCT03181594?
This trial is sponsored by Arrinex, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.